Markets remain in a holding pattern as investors await first-quarter results from five of the "Magnificent Seven" tech giants, with intense scrutiny focused on whether these companies can sustain massive capital expenditure projections. The legal dispute between Elon Musk and Sam Altman over OpenAI’s nonprofit origins and for-profit pivot highlights broader concerns regarding the sustainability of AI-driven business models and capital allocation. Meanwhile, the Federal Reserve faces a pivotal week with the potential confirmation of Kevin Warsh as Fed Chair, as economists debate the necessity of rate cuts amidst a resilient economy. Beyond tech and policy, pharmaceutical companies are targeting a multibillion-dollar market for drugs addressing Lp-a cholesterol, while budget airlines seek government relief amid rising fuel costs. Corporate communication is also evolving, evidenced by the first use of AI-generated voice clones in public earnings calls.
Sign in to continue reading, translating and more.
Continue
